Catalyst Trusteeship Limited, acting as the onshore security agent, has disclosed the creation of a new pledge over 7,538,303 equity shares of Dr. Agarwal’s Health Care Limited. These shares represent 2.38% of the issued and paid-up share capital. This development follows the release of a previous pledge on a larger block of shares. The pledge was created on August 21, 2026.
New Share Pledge Announced
Catalyst Trusteeship Limited, in its capacity as the onshore security agent for lenders to Hyperion Investments Pte. Ltd., has reported the creation of a new pledge over a substantial block of shares in Dr. Agarwal’s Health Care Limited (Target Company). The pledge, created on August 21, 2026, impacts 7,538,303 equity shares, which constitute 2.38% of the issued and paid-up share capital of the Target Company.
Background of the Pledge
These shares were part of a larger set of shares previously released from an encumbrance on August 11, 2026. The current pledge arrangement is established under a facility agreement dated March 26, 2024, where Hyperion Investments Pte. Ltd. is the borrower. Previously, on February 6, 2025, a disclosure was made under Regulation 29(1) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, concerning the initial pledge. A subsequent disclosure under Regulation 29(2) was made on August 13, 2026, following the release of a pledge over 31,698,303 shares.
Share Capital Details
As of August 21, 2026, before this new pledge, the total share capital of Dr. Agarwal’s Health Care Limited comprised 316,983,028 fully paid-up equity shares. Following the creation of the new pledge, the total number of shares encumbered by the acquirer stands at 49,033,988, representing 15.47% of the total share capital.
Source: BSE
